193 related articles for article (PubMed ID: 27234373)
21. GATA5 loss-of-function mutation in familial dilated cardiomyopathy.
Zhang XL; Dai N; Tang K; Chen YQ; Chen W; Wang J; Zhao CM; Yuan F; Qiu XB; Qu XK; Yang YQ; Xu YW
Int J Mol Med; 2015 Mar; 35(3):763-70. PubMed ID: 25543888
[TBL] [Abstract][Full Text] [Related]
22. A novel alpha-tropomyosin mutation associates with dilated and non-compaction cardiomyopathy and diminishes actin binding.
van de Meerakker JB; Christiaans I; Barnett P; Lekanne Deprez RH; Ilgun A; Mook OR; Mannens MM; Lam J; Wilde AA; Moorman AF; Postma AV
Biochim Biophys Acta; 2013 Apr; 1833(4):833-9. PubMed ID: 23147248
[TBL] [Abstract][Full Text] [Related]
23. Pediatric Dilated Cardiomyopathy-Associated
Woon MT; Long PA; Reilly L; Evans JM; Keefe AM; Lea MR; Beglinger CJ; Balijepalli RC; Lee Y; Olson TM; Kamp TJ
J Am Heart Assoc; 2018 Feb; 7(3):. PubMed ID: 29431102
[TBL] [Abstract][Full Text] [Related]
24. p53 Deletion or Hotspot Mutations Enhance mTORC1 Activity by Altering Lysosomal Dynamics of TSC2 and Rheb.
Agarwal S; Bell CM; Taylor SM; Moran RG
Mol Cancer Res; 2016 Jan; 14(1):66-77. PubMed ID: 26385560
[TBL] [Abstract][Full Text] [Related]
25. Key mediators of intracellular amino acids signaling to mTORC1 activation.
Duan Y; Li F; Tan K; Liu H; Li Y; Liu Y; Kong X; Tang Y; Wu G; Yin Y
Amino Acids; 2015 May; 47(5):857-67. PubMed ID: 25701492
[TBL] [Abstract][Full Text] [Related]
26. Digenic inheritance of mutations in the cardiac troponin (TNNT2) and cardiac beta myosin heavy chain (MYH7) as the cause of severe dilated cardiomyopathy.
Petropoulou E; Soltani M; Firoozabadi AD; Namayandeh SM; Crockford J; Maroofian R; Jamshidi Y
Eur J Med Genet; 2017 Sep; 60(9):485-488. PubMed ID: 28642161
[TBL] [Abstract][Full Text] [Related]
27. Genetic analysis resolves differential diagnosis of a familial syndromic dilated cardiomyopathy: A new case of Alström syndrome.
Lombardo B; D'Argenio V; Monda E; Vitale A; Caiazza M; Sacchetti L; Pastore L; Limongelli G; Frisso G; Mazzaccara C
Mol Genet Genomic Med; 2020 Jul; 8(7):e1260. PubMed ID: 32396277
[TBL] [Abstract][Full Text] [Related]
28. Recessive TAF1A mutations reveal ribosomopathy in siblings with end-stage pediatric dilated cardiomyopathy.
Long PA; Theis JL; Shih YH; Maleszewski JJ; Abell Aleff PC; Evans JM; Xu X; Olson TM
Hum Mol Genet; 2017 Aug; 26(15):2874-2881. PubMed ID: 28472305
[TBL] [Abstract][Full Text] [Related]
29. What makes the heart fail? New insights from defective genes.
Olson TM
Acta Paediatr Suppl; 2006 Jul; 95(452):17-21. PubMed ID: 16801160
[TBL] [Abstract][Full Text] [Related]
30. Genetics and genotype-phenotype correlations in Finnish patients with dilated cardiomyopathy.
Akinrinade O; Ollila L; Vattulainen S; Tallila J; Gentile M; Salmenperä P; Koillinen H; Kaartinen M; Nieminen MS; Myllykangas S; Alastalo TP; Koskenvuo JW; Heliö T
Eur Heart J; 2015 Sep; 36(34):2327-37. PubMed ID: 26084686
[TBL] [Abstract][Full Text] [Related]
31. Rare genetic mutations in Pakistani patients with dilated cardiomyopathy.
Shakeel M; Irfan M; Khan IA
Gene; 2018 Oct; 673():134-139. PubMed ID: 29886034
[TBL] [Abstract][Full Text] [Related]
32. Clinical impact of myocardial mTORC1 activation in nonischemic dilated cardiomyopathy.
Yano T; Shimoshige S; Miki T; Tanno M; Mochizuki A; Fujito T; Yuda S; Muranaka A; Ogasawara M; Hashimoto A; Tsuchihashi K; Miura T
J Mol Cell Cardiol; 2016 Feb; 91():6-9. PubMed ID: 26739211
[TBL] [Abstract][Full Text] [Related]
33. Genotype-phenotype associations in dilated cardiomyopathy: meta-analysis on more than 8000 individuals.
Kayvanpour E; Sedaghat-Hamedani F; Amr A; Lai A; Haas J; Holzer DB; Frese KS; Keller A; Jensen K; Katus HA; Meder B
Clin Res Cardiol; 2017 Feb; 106(2):127-139. PubMed ID: 27576561
[TBL] [Abstract][Full Text] [Related]
34. TBX20 loss-of-function mutation associated with familial dilated cardiomyopathy.
Zhao CM; Bing-Sun ; Song HM; Wang J; Xu WJ; Jiang JF; Qiu XB; Yuan F; Xu JH; Yang YQ
Clin Chem Lab Med; 2016 Feb; 54(2):325-32. PubMed ID: 26118961
[TBL] [Abstract][Full Text] [Related]
35. RagA, an mTORC1 activator, interacts with a hedgehog signaling protein, WDR35/IFT121.
Sekiguchi T; Furuno N; Ishii T; Hirose E; Sekiguchi F; Wang Y; Kobayashi H
Genes Cells; 2019 Feb; 24(2):151-161. PubMed ID: 30570184
[TBL] [Abstract][Full Text] [Related]
36. Patient-specific induced-pluripotent stem cells-derived cardiomyocytes recapitulate the pathogenic phenotypes of dilated cardiomyopathy due to a novel DES mutation identified by whole exome sequencing.
Tse HF; Ho JC; Choi SW; Lee YK; Butler AW; Ng KM; Siu CW; Simpson MA; Lai WH; Chan YC; Au KW; Zhang J; Lay KW; Esteban MA; Nicholls JM; Colman A; Sham PC
Hum Mol Genet; 2013 Apr; 22(7):1395-403. PubMed ID: 23300193
[TBL] [Abstract][Full Text] [Related]
37. Dysfunctional mTORC1 Signaling: A Convergent Mechanism between Syndromic and Nonsyndromic Forms of Autism Spectrum Disorder?
Magdalon J; Sánchez-Sánchez SM; Griesi-Oliveira K; Sertié AL
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28335463
[TBL] [Abstract][Full Text] [Related]
38. A novel TBX5 loss-of-function mutation associated with sporadic dilated cardiomyopathy.
Zhou W; Zhao L; Jiang JQ; Jiang WF; Yang YQ; Qiu XB
Int J Mol Med; 2015 Jul; 36(1):282-8. PubMed ID: 25963046
[TBL] [Abstract][Full Text] [Related]
39. Point mutations of the mTOR-RHEB pathway in renal cell carcinoma.
Ghosh AP; Marshall CB; Coric T; Shim EH; Kirkman R; Ballestas ME; Ikura M; Bjornsti MA; Sudarshan S
Oncotarget; 2015 Jul; 6(20):17895-910. PubMed ID: 26255626
[TBL] [Abstract][Full Text] [Related]
40. Whole exome sequencing identifies a KCNJ12 mutation as a cause of familial dilated cardiomyopathy.
Yuan HX; Yan K; Hou DY; Zhang ZY; Wang H; Wang X; Zhang J; Xu XR; Liang YH; Zhao WS; Xu L; Zhang L
Medicine (Baltimore); 2017 Aug; 96(33):e7727. PubMed ID: 28816949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
